ADA 2022: Recommendations From Dr. Kathleen Dungan
Dr. Kathleen Dungan, Professor of Medicine and Associate Director of Clinical Services in the Division of Endocrinology, Diabetes, and Metabolism at The Ohio State University and member of the Advisory Board for PracticeUpdate Diabetes, recommends the following presentations at the 2022 ADA Scientific Sessions, held June 3–7 in New Orleans.
Friday, June 3, 2022; 2:00 PM–4:00 PM Central Time
Clinical Diabetes/Therapeutics
Symposium: New Strategies for Insulin use in Type 2 Diabetes
- What GRADE did Insulin Therapy Achieve? Lessons on Effective Insulin Management from the GRADE Study. N Rasouli
Friday, June 3, 2022; 3:00 PM–4:00 PM Central Time
Acute and Chronic Complications
Symposium: The Role of Kidney in ASCVD
- Impact of Kidney Disease on Prescribing Drugs for ASCVD in Patients with Diabetes. JJ Neumiller
- Choice of Renal Endpoints in DKD Trials—Hard Renal Outcomes or Validated Surrogates? J Scialla
- Updated Guidelines on BP Control for Patients with Diabetes and CKD. AK Cheung
Friday, June 3, 2022; 4:15–6:15 Central Time
Epidemiology/Genetics
Symposium: Race, Racism, and Diabetes Research
- Race, Racism, and How We Provide Care in Diabetes. M Chin
- What Does the Science Tell Us about Racial Differences in A1C? E Selvin
- Perpetuating Racism through Diabetes Research. AM Tuchman
- How Race Becomes Biology. C Gravlee
Friday, June 3, 2022; 4:15 PM–6:15 PM Central Time
Clinical Diabetes/Therapeutics
Symposium: Clinical Pearls in the Practical use of Automated Insulin Delivery Systems
- Differences in Closed Loop Algorithms—Benefits and Limitations. B Kovatchev
- Practical Approaches to Insulin Dose Adjustments while on Closed Loop. DM Maahs
- Strategies to Effectively Prevent Exercise-Induced Dysglycemia while on Closed Loop. LH Messer
- Should I Eat That Burger and Fries? How to Tackle Postprandial Hyperglycemia Associated with High-Protein and High-Fat Meals. SA Weinzimer
Saturday, June 4, 2022; 1:45 PM–3:45 PM Central Time
Clinical Diabetes/Therapeutics
Symposium: Diabetes Digital Command Centers—Beam Me Up, Scottie
- Developing a Digital Command Center Infrastructure—Establishing the Federation. D Scheinker
- Data Transfer from Personal Digital Diabetes Devices—How Can It Be Done and Where Should it Go?—Diabetes Device Ecosystem. J Espinoza
- Integrating Remote Patient Monitoring and Virtual Care Delivery in the Ambulatory Setting. L Talavera
- Disseminated Models of Virtual Diabetes Care (Regional Models). AF Walker
Saturday, June 4, 2022; 4:00 PM–6:00 PM Central Time
Clinical Diabetes/Therapeutics
Symposium: Precision Diabetes Medicine—a Joint ADA/EASD Initiative
- Precision Medicine in Diabetes—Research and Next Steps to Reach Full Potential. WT Cefalu
- Precision Treatment of Type 2 Diabetes—Can Pathophysiological and Clinical Phenotypes Help Optimize Therapy? JM Dennis
- Self-Monitoring at the Intersection of Precision Medicine and Digital Health. D Kerr
- Question and Discussion Period
Monday, June 6, 2022; 8:00 AM–10:00 AM Central Time
Clinical Diabetes/Therapeutics
Symposium: Disparities in the Use of Diabetes Medications and Technologies
- Limitations in Access to New Insulin Therapies across Different Ethnicities. SJ Cromer
- Out-of-Pocket Costs and Access to Diabetes Therapies under Medicare Part D. C Dejong
- Racial and Ethnic Disparities in the use of Diabetes Technology—How to Avoid Health Inequalities in DM Technology. D Naranjo
Symposium: The Future of Insulin—Weekly, Oral, Smart, or Interchangeable Therapies
- Weekly Insulins on the Horizon. HS Bajaj
- A Pill to Swallow—Oral Insulins. G Grunberger
- Making Insulin Smarter—Glucose-Sensitive Insulin. MA Weiss
- Insulin Access & Affordability—The Role of Biosimilars and Interchangeable Insulins. RR Kalyani
Monday, June 6, 2022; 4:30–6:30 Central Time
Clinical Diabetes/Therapeutics
Symposium: ADA-EASD algorithm - Joint ADA/EASD—Management of Hyperglycemia in Type 2 Diabetes
- The Rationale and Importance of Antihyperglycemic Treatment. P Rossing
- Personalized Approach Based on Patient Characteristics and Comorbidities. JB Green
- Therapeutic Options—Lifestyle Management and Pharmacologic Treatment. VR Aroda
- Strategies for Implementing Antihyperglycemic Treatment Plan. NM Maruthur
- Key Knowledge Gaps, Question and Discussion Period. JB Buse
Monday, June 6, 2022; 4:30–6:30 Central Time
Integrated Physiology/Obesity
Symposium: Definition and Interpretation of Remission in Type 2 Diabetes
- Optimal Terminology—Can Type 2 Diabetes Remission Be Diagnosed while Glucose-Lowering Drugs Are Being Used? MA Nauck
- Glycemic Criteria for Diagnosing Remission of Type 2 Diabetes and Temporal Aspect of Diagnosing Type 2 Diabetes Remission. R Taylor
- Physiologic Considerations Regarding Remission Following Intervention with Pharmacotherapy, Lifestyle, or Metabolic Surgery and Further Questions and Unmet Needs. P Schauer
Click on any of these tags to subscribe to Topic Alerts. Once subscribed, you can get a single, daily email any time PracticeUpdate publishes content on the topics that interest you.
Visit your Preferences and Settings section to Manage All Topic Alerts
Additional Info
Disclosure statements are available on the authors' profiles: